Insider Transactions in Q4 2023 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2023
|
Havencrest Healthcare Partners, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
8,561,048
-28.66%
|
-
|
|
Dec 26
2023
|
Richard A Barasch Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+19.18%
|
-
|
|
Dec 26
2023
|
Brad Hively Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,652
+5.64%
|
-
|
|
Dec 26
2023
|
Karen Marie Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
52,000
+31.1%
|
-
|
|
Dec 26
2023
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,326
+30.55%
|
-
|
|
Dec 26
2023
|
Gabriel Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+36.68%
|
-
|
|
Dec 26
2023
|
Anne Mc George Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,000
+30.54%
|
-
|
|
Dec 26
2023
|
Maeve O'Meara Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+31.43%
|
-
|
|
Dec 26
2023
|
Mark L Pacala Director |
BUY
Grant, award, or other acquisition
|
Direct |
46,630
+25.67%
|
-
|
|
Dec 14
2023
|
Mihir Shah Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+11.73%
|
$100,000
$1.26 P/Share
|
|
Nov 30
2023
|
Jeremy Castle Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,340
+50.0%
|
-
|
|
Nov 21
2023
|
Brad Hively Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,867
-3.71%
|
$51,734
$2.19 P/Share
|
|
Nov 21
2023
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,322
-0.59%
|
$8,644
$2.19 P/Share
|
|
Nov 21
2023
|
Yale Podnos Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,530
-1.73%
|
$3,060
$2.19 P/Share
|
|
Nov 17
2023
|
Brad Hively Director |
SELL
Open market or private sale
|
Direct |
25,000
-3.46%
|
$50,000
$2.24 P/Share
|
|
Nov 17
2023
|
Brad Hively Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.35%
|
$0
$0.85 P/Share
|
|
Nov 14
2023
|
Yale Podnos Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,098
-1.16%
|
$4,196
$2.39 P/Share
|
|
Nov 14
2023
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,604
-0.62%
|
$9,208
$2.38 P/Share
|
|
Nov 14
2023
|
Brad Hively Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,117
-3.74%
|
$54,234
$2.39 P/Share
|
|
Nov 13
2023
|
Brad Hively Director |
SELL
Open market or private sale
|
Direct |
47,000
-6.09%
|
$94,000
$2.52 P/Share
|
|
Nov 13
2023
|
Brad Hively Director |
BUY
Exercise of conversion of derivative security
|
Direct |
47,000
+5.74%
|
$0
$0.85 P/Share
|